chrysarobin

andira araroba aguiar. araroba powder bahia powder brazil powder chrysatobine goa powder ringworm powder voucapoua araroba PubMed: Characterization of physical and chemical defenses in the hemlock woolly adelgid. PubMed: A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling. PubMed: Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice. PubMed: Potential feeding deterrents found in hemlock woolly adelgid, Adelges tsugae. PubMed: Cassia occidentalis L.: a review on its ethnobotany, phytochemical and pharmacological profile. PubMed: Activation of epidermal akt by diverse mouse skin tumor promoters. PubMed: Anthraquinones as defensive compounds in eggs of Galerucini leaf beetles: biosynthesis by the beetles? PubMed: Defensive components in insect eggs: are anthraquinones produced during egg development? PubMed: Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. PubMed: Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation. PubMed: Collagenase induction promotes mouse tumorigenesis by two independent pathways. PubMed: Skin tumorigenesis by initiators and promoters of different chemical structures in lines of mice selectively bred for resistance (Car-r) or susceptibility (Car-s) to two-stage skin carcinogenesis. PubMed: Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice. PubMed: Alterations in cholesterol sulfate and its biosynthetic enzyme during multistage carcinogenesis in mouse skin. PubMed: Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol. PubMed: Inhibition of the glucocorticoid receptor expression by diverse tumor promoters in SENCAR mouse epidermis. PubMed: Induction or suppression of SV40 amplification by genotoxic carcinogens, non-genotoxic carcinogens or tumor promoters. PubMed: Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice. PubMed: Effect of diverse tumor promoters on the expression of gap-junctional proteins connexin (Cx)26, Cx31.1, and Cx43 in SENCAR mouse epidermis. PubMed: The effects of calcium antagonists on anthrone skin tumor promotion and promoter-related effects in SENCAR mice. PubMed: Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice. PubMed: Elevation of transforming growth factor-alpha mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis. PubMed: Genetic factors controlling responsiveness to skin tumor promotion in mice. PubMed: Skin carcinogenesis: characteristics, mechanisms, and prevention. PubMed: Loss of mouse epidermal protein kinase C isozyme activities following treatment with phorbol ester and non-phorbol ester tumor promoters. PubMed: An EPR study of free radicals formed by antipsoriatic and tumor-promoting 9-anthrones in nonpolar solvents. PubMed: Toxicity of structurally related anthraquinones and anthrones to mammalian cells in vitro. PubMed: Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition. PubMed: Dose-response relationship in multistage carcinogenesis: promoters. PubMed: Polarographic and absorptive stripping voltammetric determination of mitoxantrone, emodin and chrysarobin using mercury and glassy carbon electrodes. PubMed: Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants. PubMed: Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice. PubMed: History of the treatment of psoriasis. PubMed: Anthralin, a non-TPA type tumor promoter, synergistically enhances phorbol ester-caused prostaglandin E2 release from primary cultured mouse epidermal cells. PubMed: Phorbol ester-mediated suppression of cytochrome P450 Cyp1a-1 induction in murine skin: involvement of protein kinase C. PubMed: [The tree, from which chrysarobin was isolated]. PubMed: Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility. PubMed: [75 years of Cignolin]. PubMed: Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents. PubMed: Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion. PubMed: Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin. PubMed: Differential mechanism for the inhibition of epidermal growth factor binding to its receptor on mouse keratinocytes by anthrones and phorbol esters. PubMed: Differential effects of various skin tumor-promoting agents on prostaglandin E2 release from primary cultures of mouse epidermal cells. PubMed: [Chemical instability of the antipsoriatic dithranol and chrysarobin in aqueous systems: oxidation behavior]. PubMed: [Synthesis, characterization, racemation and biochemical studies on 10-acylderivatives of chrysarobin: sorbylchrysarobin, beta-carbethoxypropionylchrysarobin and senecioylchrysarobin]. PubMed: [Purification, glucose-6-phosphate dehydrogenase inhibition, and HPLC analysis of four 1,8-dihydroxyanthrones]. PubMed: [The history of dermatology. On the 150th birthday of Heinrich Köbner]. PubMed: Histologic alterations produced by chrysarobin (1,8-dihydroxy-3-methyl-9-anthrone) in SENCAR mouse skin: relationship to skin tumor promoting activity. PubMed: Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. PubMed: Alterations in epidermal polyamine levels and DNA synthesis following topical treatment with chrysarobin in SENCAR mice. PubMed: Presence of a functionally altered ornithine decarboxylase activity in chrysarobin-promoted mouse epidermal papillomas. PubMed: Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones. PubMed: Modulation of chrysarobin skin tumor promotion. PubMed: Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation. PubMed: Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents. PubMed: Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice. PubMed: Effect of application frequency on epidermal ornithine decarboxylase induction by chrysarobin in SENCAR mice. PubMed: Mechanism of mouse skin tumor promotion by chrysarobin. PubMed: Anthralin: historical and current perspectives. PubMed: Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice. PubMed: Anthralin and chrysarobin: a reexamination of the origins and early use. PubMed: Structure specificity of the antipsoriatic anthrones. PubMed: [Zonal psoriasis]. PubMed: On the molecular structure of some prostaglandin receptors. PubMed: [Introduction of chrysarobin into Europe. A contribution to the history of dermatotherapy]. PubMed: Thin-layer chromatographic separation and identification of the main constituents of Chrysarobin. PubMed: [Investigations on the mechanism of action of chrysarobin and dithranol (=Cignolin) in psoriasis. Indications for a cytostatic action of these drugs]. PubMed: PSORIASIS; A STATISTICAL STUDY OF THE GOECKERMAN AND THE CHRYSAROBIN THERAPIES, AND OF VARIOUS FACTORS INFLUENCING THE CLINIC. PubMed: [Experimental studies of the mechanism of action of chrysarobin and dithranol in psoriasis (evidence for a cytostatic effect on the epidermis)]. PubMed: [ATTEMPT AT STANDARDIZATION OF CHRYSAROBIN WITH TUBIFEX]. PubMed: [ON PRODUCTION OF A PREPARATION SIMILAR TO CHRYSAROBIN FROM RHEUM PALMATUM VAR. TANGUTICUM MAXIM]. PubMed: [On the utilization of natural resources for chrysarobin production]. PubMed: Chloranil in the treatment of psoriasis; a substitute for chrysarobin. PubMed: Remarks on chronic seborrheic dermatitis of the external ear with special reference to treatment with chrysarobin. PubMed: [Our experience with chrysarobin therapy in very weak concentrations]. PubMed: [Pharmacology of chrysarobin]. PubMed: Case of Unusual Tolerance in Chrysarobin. PubMed: Deductions from Three Hundred and Nineteen Observations of the Action of Chrysarobin-a New Emeticpurge. PubMed: Anthralin/dithranol in dermatology.